Publication|Articles|May 20, 2025
Supplements and Featured Publications
- Moving Beyond SALT Scores: Advancing the Evaluation and Management of Alopecia Areata
Moving Beyond SALT Scores: Advancing the Evaluation and Management of Alopecia Areata
Listen
0:00 / 0:00
This article was sponsored by Pfizer.
This AJMC® Clinical Brief summarizes a recent roundtable to provide the experts’ overview of alopecia areata, the clinical and economic impact of the disease, and historically available and emerging tools to evaluate its severity.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Latest CME
Trending on AJMC
1
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
2
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
3
Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color
4
FDA Approves Second Generic Mifepristone Pill for Abortion
5
